Eosinophils develop in distinct stages and are recruited to peripheral sites by alternatively activated macrophages
暂无分享,去创建一个
[1] K. Takatsu,et al. Involvement of complement and fibronectin in eosinophil‐mediated damage to Nippostrongylus brasiliensis larvae , 2001, Parasite immunology.
[2] J. Drazen,et al. Characterization of a receptor for C5a anaphylatoxin on human eosinophils. , 1989, The Journal of biological chemistry.
[3] R. Ashworth,et al. Activity of rat peritoneal eosinophils following induction by different methods. , 1987, International archives of allergy and applied immunology.
[4] F. Lund,et al. Systemic Dissemination and Persistence of Th2 and Type 2 Cells in Response to Infection with a Strictly Enteric Nematode Parasite1 , 2005, The Journal of Immunology.
[5] D. Friend,et al. The murine CCR3 receptor regulates both the role of eosinophils and mast cells in allergen-induced airway inflammation and hyperresponsiveness , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[6] M. Horton,et al. Expression of IL-5 in thymocytes/T cells leads to the development of a massive eosinophilia, extramedullary eosinophilopoiesis, and unique histopathologies. , 1997, Journal of immunology.
[7] R. Locksley,et al. Analysis of type 2 immunity in vivo with a bicistronic IL-4 reporter. , 2001, Immunity.
[8] Hua Huang,et al. IL-4 Induces Differentiation and Expansion of Th2 Cytokine-Producing Eosinophils 1 , 2004, The Journal of Immunology.
[9] K. Kim,et al. Eosinophilic granulopoiesis in human fetal liver , 1993, The Anatomical record.
[10] G. Zimmerman,et al. Platelet-activating Factor , 1991 .
[11] S. Fleury,et al. Activation of the Prostaglandin D2 Receptor DP2/CRTH2 Increases Allergic Inflammation in Mouse 1 , 2005, The Journal of Immunology.
[12] D. Jones. The eosinophil. , 1993, Journal of comparative pathology.
[13] S. Nishikawa,et al. The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene , 1990, Nature.
[14] M. Cooper,et al. A novel pair of immunoglobulin-like receptors expressed by B cells and myeloid cells. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[15] Y. Aizawa,et al. Novel technique for the direct flow cytofluorometric analysis of human basophils in unseparated blood and bone marrow, and the characterization of phenotype and peroxidase of human basophils. , 1999, Cytometry.
[16] T. Graf,et al. Making Eosinophils Through Subtle Shifts in Transcription Factor Expression , 2002, The Journal of experimental medicine.
[17] M. Strath,et al. Eosinophilia in transgenic mice expressing interleukin 5 , 1990, The Journal of experimental medicine.
[18] H. Kita,et al. Constitutive production of IL-4 and IL-10 and stimulated production of IL-8 by normal peripheral blood eosinophils. , 1996, Journal of immunology.
[19] M. Litt. STUDIES IN EXPERIMENTAL EOSINOPHILIA , 1961, The Journal of cell biology.
[20] P. Loke,et al. A Brugia malayi Homolog of Macrophage Migration Inhibitory Factor Reveals an Important Link Between Macrophages and Eosinophil Recruitment During Nematode Infection1 , 2001, The Journal of Immunology.
[21] S. Rankin,et al. Eotaxin induces a rapid release of eosinophils and their progenitors from the bone marrow. , 1998, Blood.
[22] P. Foster,et al. Relationship between interleukin-5 and eotaxin in regulating blood and tissue eosinophilia in mice. , 1997, The Journal of clinical investigation.
[23] J. Miyazaki,et al. Defective B-1 cell development and impaired immunity against Angiostrongylus cantonensis in IL-5R alpha-deficient mice. , 1996, Immunity.
[24] L. Lanier,et al. Activation of Natural Killer Cells and Dendritic Cells upon Recognition of a Novel CD99-like Ligand by Paired Immunoglobulin-like Type 2 Receptor , 2004, The Journal of experimental medicine.
[25] D. Voehringer,et al. Type 2 immunity reflects orchestrated recruitment of cells committed to IL-4 production. , 2004, Immunity.
[26] D. Voehringer,et al. Type 2 immunity is controlled by IL-4/IL-13 expression in hematopoietic non-eosinophil cells of the innate immune system , 2006, The Journal of experimental medicine.
[27] S. Gordon. Alternative activation of macrophages , 2003, Nature Reviews Immunology.
[28] A. Gessner,et al. Mast Cells, Basophils, and Eosinophils Acquire Constitutive IL-4 and IL-13 Transcripts during Lineage Differentiation That Are Sufficient for Rapid Cytokine Production1 , 2005, The Journal of Immunology.
[29] A. Wardlaw,et al. Platelet-activating factor. A potent chemotactic and chemokinetic factor for human eosinophils. , 1986, The Journal of clinical investigation.
[30] B. Aronow,et al. Eotaxin-3 and a uniquely conserved gene-expression profile in eosinophilic esophagitis. , 2006, The Journal of clinical investigation.
[31] N. Sarvetnick,et al. STAT4/6-dependent differential regulation of chemokine receptors. , 2006, Clinical immunology.
[32] D. Vinatier,et al. Decreased expression of eosinophil peroxidase and major basic protein messenger RNAs during eosinophil maturation. , 1992, Blood.
[33] T. Fujita,et al. Carbohydrate-binding specificities of mouse ficolin A, a splicing variant of ficolin A and ficolin B and their complex formation with MASP-2 and sMAP , 2005, Immunogenetics.
[34] G. Mayrhofer,et al. Trapping and Immobilization ofNippostrongylus brasiliensis Larvae at the Site of Inoculation in Primary Infections of Interleukin-5 Transgenic Mice , 1999, Infection and Immunity.
[35] R. Locksley,et al. Helper T cells regulate type-2 innate immunity in vivo , 2002, Nature.
[36] K. Akashi,et al. Identification of eosinophil lineage–committed progenitors in the murine bone marrow , 2005, The Journal of experimental medicine.
[37] P. Crocker,et al. The murine inhibitory receptor mSiglec‐E is expressed broadly on cells of the innate immune system whereas mSiglec‐F is restricted to eosinophils , 2004, European journal of immunology.
[38] M. Rothenberg,et al. Peyer's patch eosinophils: identification, characterization, and regulation by mucosal allergen exposure, interleukin-5, and eotaxin. , 2000, Blood.
[39] S. Orkin,et al. Targeted Deletion of a High-Affinity GATA-binding Site in the GATA-1 Promoter Leads to Selective Loss of the Eosinophil Lineage In Vivo , 2002, The Journal of experimental medicine.
[40] L. Hassman,et al. Pulmonary Chemokine Expression Is Coordinately Regulated by STAT1, STAT6, and IFN-γ , 2004, The Journal of Immunology.
[41] P. Hodgkin,et al. IL-5-deficient mice have a developmental defect in CD5+ B-1 cells and lack eosinophilia but have normal antibody and cytotoxic T cell responses. , 1996, Immunity.
[42] A. Luster,et al. Molecular and Biological Characterization of the Murine Leukotriene B4 Receptor Expressed on Eosinophils , 1998, The Journal of experimental medicine.
[43] Qingxian Lu,et al. Macrophage regulation by Tyro 3 family receptors. , 2003, Current opinion in immunology.
[44] M. Baggiolini,et al. Eotaxin-2, a Novel CC Chemokine that Is Selective for the Chemokine Receptor CCR3, and Acts Like Eotaxin on Human Eosinophil and Basophil Leukocytes , 1997, The Journal of experimental medicine.
[45] P. Foster,et al. Eosinophils Promote Allergic Disease of the Lung by Regulating CD4+ Th2 Lymphocyte Function1 , 2001, The Journal of Immunology.
[46] P. Weller,et al. Lymph node trafficking and antigen presentation by endobronchial eosinophils. , 2000, The Journal of clinical investigation.
[47] P. Giacomin,et al. Loss of Complement Activation and Leukocyte Adherence as Nippostrongylus brasiliensis Develops within the Murine Host , 2005, Infection and Immunity.